Angiotensin-(1-7) central administration induces anxiolytic-like effects in elevated plus maze and decreased oxidative stress in the amygdala

Journal of Affective Disorders

Volumn 145, Issue 2, 2013, Pages 165-171

  Bild, Walther ^a   Ciobica, Alin ^b  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b ALEXANDRU IOAN CUZA UNIVERSITY OF IASI   (Romania)

Author keywords

Angiotensin (1 7); Anxiety; Oxidative stress

Indexed keywords

ANGIOTENSIN[1-7]; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; LIPID PEROXIDATION; MAZE TEST; MOTOR ACTIVITY; NONHUMAN; OXIDATIVE STRESS; PEROXIDATION; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

AMYGDALA; ANGIOTENSIN I; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; MALE; MAZE LEARNING; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR;

EID: 84872875844     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2012.07.024     Document Type: Article

References (62)

1. N. Alenina, P. Xu, B. Rentzsch, E.L. Patkin, and M. Bader Genetically altered animal models for Mas and angiotensin-(1-7) Experimental Physiology 93 2008 528 537
2. N.A. Antelava, N.V. Gongadze, and M.I. Gogolauri Comparative characteristics of angiotensin-converting enzyme inhibitor captopril and the angiotensin II receptor blockers losartan action on the oxidative metabolism in experimental hyperlipidemia in rabbits Georgian Medical News 150 2007 57 60
3. D.L. Armstrong, E.A. Garcia, T. Ma, B. Quinones, and M.J. Wayner Angiotensin II blockade of long-term potentiation at the perforant path-granule cell synapse in vitro Peptides 17 1996 689 693
4. N. Basso, R. Cini, A. Pietrelli, L. Ferder, and N.A. Terragno Protective effect of long-term angiotensin II inhibition American Journal of Physiology - Heart and Circulatory Physiology 293 2007 1351 1358
5. I.F. Benter, M.H. Yousif, G.S. Dhaunsi, J. Kaur, M.C. Chappell, and D.I. Diz Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats American Journal of Nephrology 28 2008 25 33
6. D.C. Blanchard, G. Griebel, and R.J. Blanchard Mouse defensive behaviors: pharmacological and behavioral assays for anxiety and panic Neuroscience and Biobehavioral Reviews 25 2001 205 218
7. J. Bouayed, H. Rammal, and R. Soulimani Oxidative stress and anxiety: relationship and cellular pathways Oxidative Medicine and Cellular Longevity 2 2009 63 67
8. J. Bouayed, H. Rammal, C. Younos, and R. Soulimani Positive correlation between peripheral blood granulocyte oxidative status and level of anxiety in mice European Journal of Pharmacology 564 2007 146 149
9. J.J. Braszko, A. Kułakowska, and M.M. Winnicka Effects of angiotensin II and its receptor antagonists on motor activity and anxiety in rats Journal of Physiology and Pharmacology 54 2003 271 281
10. T. Chabrashvili, C. Kitiyakara, J. Blau, A. Karber, and S. Aslam Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 285 2003 R117 R124
11. D.S. Charrey Neuroanatonical circuits modulating fear and anxiety Acta Psychiatrica Scandinavica 417 2003 38 50
12. A. Ciobica, W. Bild, L. Hritcu, and I. Haulica Brain renin-angiotensin system in cognitive function: preclinical findings and implications for prevention and treatment of dementia Acta Neurologica Belgica 109 2009 171 180
13. A. Ciobica, L. Hritcu, M. Padurariu, R. Dobrin, and V. Bild Effects of serotonin depletion on behavior and neuronal oxidative stress status in rat: relevance for anxiety and affective disorders Advances in Medical Sciences 55 2010 289 296
14. A. Ciobica, Z. Olteanu, M. Padurariu, and L. Hritcu The effects of pergolide on memory and oxidative stress in a rat model of Parkinson's disease Journal of Physiology and Biochemistry 68 2012 59 69
15. A. Ciobica, V. Bild, L. Hritcu, M. Padurariu, and W. Bild Effects of angiotensin II receptor antagonists on anxiety and some oxidative stress markers in rat Central European Journal of Medicine 6 2011 331 340
16. A. Ciobica, W. Bild, L. Hritcu, V. Artenie, and I. Haulica The importance of oxidative stress in angiotensin II-mediated effects on cognitive functions Neuropeptides 43 2009 420 421
17. A.P.M. Cruz, F. Frei, and F.G. Graeff Ethopharmacological analysis of rat behavior on the elevated plus-maze Pharmacology Biochemistry and Behavior 49 1994 171 176
18. P.A. Deddish, B. Marcic, H.L. Jackman, H. Wang, R.A. Skidgel, and E.G. Erdos N-domain specific substrate and C-domain inhibitors of angiotensinconverting enzyme: angiotensin-(1-7) and keto-ACE Hypertension 31 1998 912 917
19. C. Desrumaux, P.Y. Risold, H. Schroeder, V. Deckert, D. Masson, A. Athias, H. Laplanche, N. Le Guern, D. Blache, X.C. Jiang, A.R. Tall, D. Desor, and L. Lagrost Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content and increases anxiety in mice FASEB Journal 19 2005 296 297
20. E.F. Espejo Effects of weekly or daily exposure to the elevated plus-maze in male mice Behavioural Brain Research 87 1997 233 238
21. E.F. Espejo Structure of the mouse behavior on the elevated plus maze test of anxiety Behavioural Brain Research 86 1997 105 112
22. D. Felix, M.C. Khosla, K.L. Barnes, H. Imboden, B. Montani, and C.M. Ferrario Neurophysiological responses to angiotensin-(l-7) Hypertension 17 1991 1113 1114
23. P.R. Gard Angiotensin as a target for the treatment of Alzheimer's disease, anxiety and depression Expert Opinion on Therapeutic Targets 8 2004 7 14
24. S. Gonzales, G.O. Noriega, M.L. Tomaro, and C. Peña Angiotensin-(1-7) stimulates oxidative stress in rat kidney Regulatory Peptides 106 2002 67 70
25. I. Haulica, W. Bild, and D.N. Serban Angiotensin peptides and their pleiotropic actions Journal of the Renin-Angiotensin-Aldosterone System 6 2005 121 131
26. K. Hellner, T. Walther, M. Schubert, and D. Albrecht Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas Molecular and Cellular Neuroscience 29 2005 427 435
27. I. Hovatta, J. Juhila, and J. Donner Oxidative stress in anxiety and comorbid disorders Neuroscience Research 68 2010 261 275
28. I. Hovatta, R.S. Tennant, R. Helton, R.A. Marr, O. Singer, J.M. Redwine, J.A. Ellison, E.E. Schadt, I.M. Verma, D.J. Lockhart, and C. Barlow Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice Nature 438 2005 662 666
29. R.N. Hughes, C.L. Lowther, and M. van Nobelen Prolonged treatment with vitamins C and E separately and together decreases anxiety-related open-field behavior and acoustic startle in hooded rats Pharmacology Biochemistry and Behavior 97 2011 494 499
30. A.V. Kalueff, and P. Tuohimaa Mouse grooming microstructure is a reliable anxiety marker bidirectionally sensitive to GABAergic drugs European Journal of Pharmacology 508 2005 147 153
31. E. Kostenis, G. Milligan, A. Christopoulos, C.F. Sanchez-Ferrer, and S. Heringer-Walther G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor Circulation 111 2005 1806 1813
32. A. Kulakowska, W. Karwowska, K. Wisniewski, and J.J. Braszko Losartan influences behavioural effects of angiotensin II in rats Pharmacological Research 34 1996 109 115
33. X.X. Liao, R.X. Guo, H. Ma, L.C. Wang, Z.H. Chen, C.T. Yang, and J.Q. Feng Effects of angiotensin-(1-7) on oxidative stress and functional changes of isolated rat hearts induced by ischemia-reperfusion Nan Fang Yi Ke Da Xue Xue Bao 28 2008 1345 1348
34. R.G. Lister Ethologically-based animal models of anxiety disorders Pharmacology & Therapeutics 46 1990 321 340
35. R.D. Machado, R.A. Santos, and S.P. Andrade Opposing actions of angiotensins on angiogenesis Life Sciences 66 2000 67 76
36. J.M. Mahon, M. Allen, J. Herbert, and J.T. Fitzsimons The association of thirst, sodium appetite and vasopressin release with c-fos expression in the forebrain of the rat after intracerebroventricular injection of angiotensin II, angiotensin-(1-7) or carbachol Neuroscience 69 1995 199 208
37. A. Masood, A. Nadeem, S.J. Mustafa, and J.M. O'Donnell Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice Journal of Pharmacology and Experimental Therapeutics 326 2008 369 379
38. M. Matsushita, T. Kumano-Go, N. Suganuma, H. Adachi, S. Yamamura, H. Morishima, Y. Shigedo, A. Mikami, M. Takeda, and Y. Sugita Anxiety, neuroticism and oxidativestress: cross-sectional study in non-smoking college students Psychiatry and Clinical Neurosciences 4 2010 435 441
39. M.J. Mc Kinley, A.L. Albiston, A.M. Allen, M.L. Mathai, and C.N. May The brain renin-angiotensin system: location and physiological roles International Journal of Biochemistry & Cell Biology 35 2003 901 918
40. J. Menon, D.R. Soto-Pantoja, M.F. Callahan, J.M. Cline, C.M. Ferrario, E.A. Tallant, and P.E. Gallagher Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2 Cancer Research 67 2007 2809 2815
41. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates 2006 Academic Press, Elsevier San Diego
42. H. Rammal, J. Bouayed, C. Younos, and R. Soulimani Evidence that oxidative stress is linked to anxiety related behavior in mice Brain, Behavior, and Immunity 22 2008 1156 1159
43. H. Rammal, J. Bouayed, C. Younos, and R. Soulimani The impact of high anxiety levels on the oxidative status of mouse peripheral blood lymphocytes, granulocytes and monocytes European Journal of Pharmacology 589 2008 173 175
44. R.J. Rodgers, and A. Dalvi Anxiety, defense and the elevated plus-maze Neuroscience and Biobehavioral Reviews 21 1997 801 810
45. S. Salim, M. Asghar, G. Chugh, M. Taneja, Z. Xia, and K. Saha Oxidative stress: a potential recipe for anxiety, hypertension and insulin resistance Brain Research 1359 2010 178 185
46. W.O. Sampaio, C. Henrique de Castro, R.A. Santos, E.L. Schiffrin, and R.M. Touyz Angiotensin-(1-7) counterregulates Angiotensin II signaling in human endothelial cells Hypertension 50 2007 1093 1098
47. R.A. Santos, E. Simoes, A.C. Silva, C. Maric, D.M. Silva, and R.P. Machado Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas Proceedings of the National Academy of Sciences of the United States of America 100 2003 8258 8263
48. R.A.S. Santos, M.J. Campagnole-Santos, and S.P. Andrade Angiotensin-(1-7): an update Regulatory Peptides 91 2000 45 62
49. H. Sies Oxidative stress: oxidants and antioxidants Experimental Physiology 82 1997 291 295
50. C.G. Souza, J.D. Moreira, I.R. Siqueira, A.G. Pereira, D.K. Rieger, and D.O. Souza Highly palatable diet consumption increases protein oxidation in rat frontal cortex and anxiety like behavior Life Sciences 81 2007 198 203
51. J. Srinivasan, B. Suresh, and M. Ramanathan Differential anxiolytic effect of enalapril and losartan in normotensive and renal hypertensive rats Physiology and Behavior 78 2003 585 591
52. E.A. Tallant, C.M. Ferrario, and P.E. Gallagher Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor American Journal of Physiology - Heart and Circulatory Physiology 289 2005 H1560 H1566
53. B. Tom, A. Dendorfer, and A.H. Jan Danser Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact International Journal of Biochemistry & Cell Biology 35 2003 792 801
54. O. von Bohlen und Halbach, and D. Albrecht The CNS rennin angiotensin system Cell and Tissue Research 326 2006 599 616
55. O. von Bohlen und Halbach Angiotensin IV in the central nervous system Cell and Tissue Research 311 2003 1 9
56. O. von Bohlen und Halbach, and D. Albrecht Angiotensin II inhibits long-term potentiation within the lateral nucleus of the amygdala through AT1 receptors Peptides 19 1998 1031 1036
57. O. von Bohlen und Halbach, T. Walther, M. Bader, and D. Albrecht Interaction between Mas and the Angiotensin AT1 receptor in the amygdala Journal of Neurophysiology. 83 2000 2012 2021
58. P.M. Wall, and C. Messier Ethological confirmatory factor analysis of anxiety-like behavior in the murine elevated plus-maze Behavioural Brain Research 114 2000 199 212
59. T. Walther, D. Balschun, J.P. Voigt, H. Fink, and W. Zuschratter Sustained long term potentiation and anxiety in mice lacking the Mas protooncogene Journal of Biological Chemistry 273 1998 11867 11873
60. T. Walther, J.P. Voigt, H. Fink, and M. Bader Sex specific behavioural alterations in Mas-deficient mice Behavioural Brain Research 107 2000 105 109
61. D. Wang, T. Chabrashvili, L. Borrego, S. Aslam, and J.G. Umans Angiotensin II infusion alters vascular function in mouse resistance vessels: roles of O and endothelium Journal of Vascular Research 43 2006 109 119
62. K. Yasunari, T. Matsui, K. Maeda, M. Nakamura, T. Watanabe, and N. Kiriike Anxiety-induced plasma norepinephrine augmentation increases reactive oxygen species formation by monocytes in essential hypertension American Journal of Hypertension 19 2006 573 578